Delivery Order SPE2DB20D9135-SPE2DB23FZW45

Award Date 5/31/23
Potential Completion Date 6/1/23
Potential Value $18K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $18,488.12, was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is a delivery order for the specialized medication Trikafta, under a broader Indefinite Delivery Contract (IDC) valued at $499,999,999 that DMS Pharmaceutical Group holds with the DLA. This IDC enables the DLA to issue firm fixed-price delivery orders for a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $18,488.12, is a firm fixed-price delivery order for the pharmaceutical product Trikafta. This contract is part of a larger Indefinite Delivery Contract (IDC) between DMS Pharmaceutical Group and the DLA, valued at $499,999,999 and valid through November 2026. The IDC enables...
This federal contract award, valued at $37,053.68, was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is a delivery order under an indefinite delivery contract (IDC) valued at up to $499,999,999 that DMS Pharmaceutical Group holds with the DLA. This IDC, under the SPE2DB program, allows the DLA to issue firm fixed-price delivery orders for a comprehensive range of...
This is a federal contract award made by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $18,526.82, is a firm fixed-price delivery order for the pharmaceutical product Trikafta. This award is part of a larger Indefinite Delivery Contract (IDC) with DMS Pharmaceutical Group valued at $499,999,999, which allows the DLA to issue delivery orders for a comprehensive...
The federal contract award is valued at $55,580.49 and was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The award is a delivery order under a larger indefinite delivery contract (IDC) valued up to $499,999,999 that DMS Pharmaceutical Group holds with DLA. This single-award IDC, under the SPE2DB program, allows DLA to issue firm fixed-price delivery orders for a comprehensive range of pharmaceutical...
This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is a $36,976.24 firm fixed-price delivery order for the specialized medication Trikafta, with an ultimate completion date of January 8, 2025. This contract is part of a larger $499,999,999 Indefinite Delivery Contract (IDC) held by DMS Pharmaceutical Group with the DLA under the SPE2DB...
The U.S. Defense Logistics Agency (DLA) awarded a $18,526.83 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. This order for the drug Trikafta is being fulfilled under a larger single-award indefinite delivery contract (IDC), valued up to $499,999,999, awarded to DMS by the DLA. The IDC, which runs through December 31, 2025, allows the DLA to issue delivery orders for a comprehensive range of...
This federal contract award, valued at $18,526.83, was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is a firm fixed-price delivery order for the supply of a pharmaceutical product called TRIKAFTA 100-50-75 MG/150 MG UU 84S. This award is part of a larger indefinite delivery contract (IDC) that DMS Pharmaceutical Group holds with the DLA under the SPE2DB program,...
This federal contract award, valued at $111,160.98, was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is a firm fixed-price delivery order under the DLA's SPE2DB Medical Supply Chain program, which allows the agency to fulfill recurring pharmaceutical and medical supply needs of military health facilities worldwide. This award is part of a larger $499,999,999...
The Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract worth $37,053.68 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the delivery of Trikafta, a specialized pharmaceutical product, with an ultimate completion date of April 10, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) valued at $499,999,999 that DMS Pharmaceutical Group holds with the DLA...
  • SPE2DB20D9135
    Indefinite Delivery Contract
  • SPE2DB20D9135-SPE2DB23FZW45
    Delivery Order

This federal contract award, valued at $18,318.75, was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The award is a delivery order under a larger indefinite delivery contract (IDC) with the DLA, valued at up to $499,999,999, which runs through December 31, 2025. This IDC allows the DLA to issue firm fixed-price delivery orders for a comprehensive range of pharmaceutical items, including common medications as well as specialized drugs and medical supplies, to fulfill the recurring medical supply needs of military health facilities worldwide. The current award, with a completion date of June 1, 2023, is for the provision of the drug Trikafta. This contract has no set-aside designation.

Generated 1/9/25, 9:36 AM